Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI evaluation of ozoralizumab efficacy in rheumatoid arthritis
jRCTs011250019Recruiting
- Sponsor
- Hokkaido University Hospital
- Start
- Jan 2026
- Modality
- Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of ozoralizumab in rheumatoid arthritis (RA), sponsored by Hokkaido University Hospital. Primary endpoint: Change in functional connectivity. Started Jan 2026; status: recruiting.
02
Drugs
ozoralizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCTs011250019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011250019.